Hem Pandya has over 25 years experience in the generics industry. Hem joined Mayne Pharma in Oct 2021 as Head of the Generic Products Division and recently served as an advisor to AmeriSourceBergen’s Global Sourcing Group. He was the co-Founder & Chief Executive Officer of Vensun Pharmaceuticals, Inc., a generic specialty pharmaceutical company which was sold to Strides Pharmaceuticals, Inc. in 2019. Prior to Vensun, he was the President & Chief Executive Officer of Teligent (IGI) Inc.